Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 227,741,321 papers from all fields of science
Search
Sign In
Create Free Account
Cefepime:MCnc:Pt:Ser/Plas:Qn
Known as:
Tsefepiim:MCnc:Pt:S/P:Qn
, cefepima:concentración de masa:punto en el tiempo:suero/plasma:cuantitativo
, ????:????:????:??/??:??
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
Plas
Serum
Unit of Mass Concentration
cefepime
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Perbandingan Efektifitas Antara Monoterapi Empiris Seftazidime dan Sefepim Pada Anak Leukemia Limfoblastik Akut dengan Demam Neutropenia
Filla Reviyani Suryaningrat
,
Aris Primadi
,
Alex Chairulfatah
Sari Pediatri
2019
Corpus ID: 203353160
Latar belakang. Demam neutropenia pada leukemia limfoblastik akut (LLA) termasuk kegawatan onkologi yang harus mendapatkan…
Expand
2014
2014
Neurotoxicidad por cefepima en un paciente con insuficiencia renal moderada
M. V. Currius
,
L. G. Santanach
,
A. Plasencia
,
M. I. M. Pintiado
,
M. T. Izaga
2014
Corpus ID: 177220630
Presentamos el caso de una probable neurotoxicidad inducida por cefepima en una mujer pluripatologica de 82 anos. La…
Expand
2007
2007
Informe Cefepima 1g inyectable
Dirección General de Medicamentos
,
Insumos y Drogas
,
Ministerio de Salud
2007
Corpus ID: 182566840
2006
2006
ENCEFALOPATIA POR CEFEPIMA
E. O. Garces
,
C. Rech
,
+4 authors
F. Thomé
2006
Corpus ID: 78512161
Cefepime is a fourth-generation cephalosporin antibiotic commonly prescribed for severe infections. Its most serious adverse…
Expand
2004
2004
Comparison of Cefepime and Meropenem Use in Treatment of Neutropenic Fever
A. Atay
,
E. Kısmet
,
+4 authors
O. Özcan
2004
Corpus ID: 53883116
Bu çalışma, hematolojik malignite ve solid tümörlü hastalarda nötropenik dönemlerde ortaya çıkan febril atakların ampirik…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE